Company page
Immunome, Inc.
Immunome, Inc. is a public biotechnology company traded under the ticker IMNM in the American market. The company has a market capitalization of approximately $2.12 billion. Immunome focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- IMNM:NASDAQ
- Asset type
- Stock
- Market cap
- $2.12B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD